The newly formed organization aims to serve as a central platform for advancing research, fostering innovation, and strengthening connections among scientists, clinicians, and stakeholders working in neuroimmunology. By bringing together expertise from across the field, DGNIM seeks to support scientific progress and encourage interdisciplinary exchange.

With its formal launch, the society is now inviting researchers and professionals to join the initiative and contribute to shaping the future of neuroimmunology. Membership details are available via the organization’s official website: https://dgnim.de/ and updates can also be followed through its presence on LinkedIn.

As part of its inaugural activities, DGNIM has announced its first official meeting, scheduled to take place from November 23 to 25, 2026, at Kloster Schöntal. The event is expected to serve as a key opportunity for networking, collaboration, and setting future directions for the society.

Ari Waisman and the DGNIM team expressed enthusiasm about the society’s launch and the opportunities ahead, emphasizing their commitment to building a strong and collaborative neuroimmunology community.